Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults Yanchun Che , Xiaoqiang Liu , Yi Pu , Meijian Zhou , Zhimei Zhao , Ruiju Jiang , Zhifang Yin , Mingjue Xu , Qiongzhou Yin , Jianfeng Wang , Jing Pu , Heng Zhao , Ying Zhang , Lichun Wang , Ya Jiang , Jin Lei , Yan Zheng , Yun Liao , Runxiang Long , Li Yu , Pingfang Cui , Huijuan Yang , Yuehui Zhang , Jingyu Li , Weiwu Chen , Zhanlong He , Kaili Ma , Chao Hong , Dandan Li , Guorun Jiang , Donglan Liu , Xingli Xu , Shengtao Fan , Chen Cheng , Hongling Zhao , Jianbo Yang , Yan Li , Yanxiang Zou , Youshuai Zhu , Yaling Zhou , Yingqiu Guo , Ting Yang , Hongbo Chen , Zhongping Xie , Changgui Li , Qihan Li Clinical Infectious Diseases（2020）
Key words
inactivated SARS-CoV-2 vaccine, phase 2 trial, immunogenicity, safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
